Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and <i>FLT3</i> internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Jakob Passweg, Charles Craddock, Didier Blaise, Jan J. Cornelissen, Liisa Volin, Nigel H. Russell, Gérard Socié, Mauricette Michallet, Nathalie Fegueux, Patrice Chevallier, Arne Brecht, Mathilde Hunault-Berger, Mohamad Mohty, Jordi Esteve, Arnon Nagler

Open source

DOI
10.3324/haematol.2017.178251
Published
2017-12-14
Container
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2017.178251,
  title = {Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and
            <i>FLT3</i>
            internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation},
  author = {Xavier Poiré and Myriam Labopin and Emmanuelle Polge and Jakob Passweg and Charles Craddock and Didier Blaise and Jan J. Cornelissen and Liisa Volin and Nigel H. Russell and Gérard Socié and Mauricette Michallet and Nathalie Fegueux and Patrice Chevallier and Arne Brecht and Mathilde Hunault-Berger and Mohamad Mohty and Jordi Esteve and Arnon Nagler},
  year = {2017},
  journal = {Haematologica},
  doi = {10.3324/haematol.2017.178251},
  url = {https://doi.org/10.3324/haematol.2017.178251}
}

RIS

TY  - JOUR
TI  - Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and
            <i>FLT3</i>
            internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
AU  - Xavier Poiré
AU  - Myriam Labopin
AU  - Emmanuelle Polge
AU  - Jakob Passweg
AU  - Charles Craddock
AU  - Didier Blaise
AU  - Jan J. Cornelissen
AU  - Liisa Volin
AU  - Nigel H. Russell
AU  - Gérard Socié
AU  - Mauricette Michallet
AU  - Nathalie Fegueux
AU  - Patrice Chevallier
AU  - Arne Brecht
AU  - Mathilde Hunault-Berger
AU  - Mohamad Mohty
AU  - Jordi Esteve
AU  - Arnon Nagler
PY  - 2017
JO  - Haematologica
DO  - 10.3324/haematol.2017.178251
UR  - https://doi.org/10.3324/haematol.2017.178251
ER  - 

APA

Poiré, X., Labopin, M., Polge, E., Passweg, J., Craddock, C., Blaise, D., Cornelissen, J. J., Volin, L., Russell, N. H., Socié, G., Michallet, M., Fegueux, N., Chevallier, P., Brecht, A., Hunault-Berger, M., Mohty, M., Esteve, J., & Nagler, A. (2017). Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and <i>FLT3</i> internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. https://doi.org/10.3324/haematol.2017.178251

Source records